BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16296737)

  • 1. Targeted drug delivery to mammalian mitochondria in living cells.
    Weissig V
    Expert Opin Drug Deliv; 2005 Jan; 2(1):89-102. PubMed ID: 16296737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial pharmaceutics.
    Weissig V; Cheng SM; D'Souza GG
    Mitochondrion; 2004 Mar; 3(4):229-44. PubMed ID: 16120357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
    Yamada Y; Harashima H
    Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting drugs to mitochondria.
    Heller A; Brockhoff G; Goepferich A
    Eur J Pharm Biopharm; 2012 Sep; 82(1):1-18. PubMed ID: 22687572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
    Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
    Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria.
    Horobin RW; Trapp S; Weissig V
    J Control Release; 2007 Aug; 121(3):125-36. PubMed ID: 17658192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes and liposome-like vesicles for drug and DNA delivery to mitochondria.
    Weissig V; Boddapati SV; Cheng SM; D'Souza GG
    J Liposome Res; 2006; 16(3):249-64. PubMed ID: 16952879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast models of human mitochondrial diseases: from molecular mechanisms to drug screening.
    Schwimmer C; Rak M; Lefebvre-Legendre L; Duvezin-Caubet S; Plane G; di Rago JP
    Biotechnol J; 2006 Mar; 1(3):270-81. PubMed ID: 16897707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial-targeted drug and DNA delivery.
    Weissig V
    Crit Rev Ther Drug Carrier Syst; 2003; 20(1):1-62. PubMed ID: 12911263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondriotropic liposomes.
    Boddapati SV; Tongcharoensirikul P; Hanson RN; D'Souza GG; Torchilin VP; Weissig V
    J Liposome Res; 2005; 15(1-2):49-58. PubMed ID: 16194927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting mitochondria: strategies, innovations and challenges: The future of medicine will come through mitochondria.
    Edeas M; Weissig V
    Mitochondrion; 2013 Sep; 13(5):389-90. PubMed ID: 23562877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients.
    Liu J; Shen W; Zhao B; Wang Y; Wertz K; Weber P; Zhang P
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1343-52. PubMed ID: 19716392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial leader sequence--plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria.
    D'Souza GG; Boddapati SV; Weissig V
    Mitochondrion; 2005 Oct; 5(5):352-8. PubMed ID: 16154389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience/biomaterial interface.
    Whittlesey KJ; Shea LD
    Exp Neurol; 2004 Nov; 190(1):1-16. PubMed ID: 15473976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; VĂ©csei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian mitochondrial proteomics: insights into mitochondrial functions and mitochondria-related diseases.
    Chen X; Li J; Hou J; Xie Z; Yang F
    Expert Rev Proteomics; 2010 Jun; 7(3):333-45. PubMed ID: 20536306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial medicine and therapeutics, Part II. Preface.
    Hamm-Alvarez S; Cadenas E
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1233. PubMed ID: 19835920
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitochondria as targets for established and novel anti-cancer agents.
    Grad JM; Cepero E; Boise LH
    Drug Resist Updat; 2001 Apr; 4(2):85-91. PubMed ID: 11512525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From serendipity to mitochondria-targeted nanocarriers.
    Weissig V
    Pharm Res; 2011 Nov; 28(11):2657-68. PubMed ID: 21833792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.